Presentation (CTI)

OBJECTIVES: This study investigates the motivating mechanisms behind corporate participation in health governance by analyzing why and how companies engage in these activities. The research explores internal and external driving forces influencing corporate involvement, including market competition, corporate management, and economic benefits, aiming to clarify these dynamics and provide insights for building more inclusive health governance systems.
METHODS: The research methodology combines literature review with empirical analysis. First, existing literature on health governance and corporate participation was systematically reviewed to identify research gaps and understand the current state of health governance and corporate involvement. Second, CSMAR database was utilized to collect data from annual ESG reports of companies listed on Shanghai, Shenzhen, and Beijing stock exchanges from 2009 to 2023. Text recognition, word segmentation, and keyword frequency statistics were conducted on these reports. The collected data was then analyzed using Generalized Linear Models (GLM) and Qualitative Comparative Analysis (QCA) to verify the influence of various motivating factors on corporate participation in health governance and identify specific pathways of influence.
RESULTS: The study reveals three key findings: (1) tax incentive policies positively affect corporate participation in health governance, with more profitable companies demonstrating greater willingness to implement sustained initiatives; (2) market competition and consumer preferences significantly influence corporate involvement, while monopolistic enterprises show reduced investment; (3) motivating mechanisms exhibit diversity with no single pathway showing high unique coverage, indicating the absence of a unified behavioral pattern.
CONCLUSIONS: Corporate participation in health governance is influenced by profitability, market competition, and other variables, resulting in contextualized engagement patterns. Companies actively adjust their strategies based on internal and external factors. Policy recommendations include strengthening tax mechanisms, optimizing market competition guidance, enhancing consumer supervision, supporting internal governance, and implementing reasonable institutional guidance to improve public health governance and help companies fulfill social responsibilities while enhancing sustainable development.